The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Bellicum Pharmaceuticals (BLCM) been one of those stocks this ...
Shares of Bellicum Pharmaceuticals BLCM lost 50.1% on Mar 15 after management announced that it has decided to discontinue the ongoing phase I/II studies evaluating its GoCAR-T cell product candidates ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results